AIM OF THE STUDY: Hancornia speciosa Gomes (Apocynaceae) is a tree that is widely distributed throughout Brazil. Its latex is collected and used extensively to treat acne, warts, diseases related to bursitis, and inflammation. In this work, we describe the anti-inflammatory effects of the latex. MATERIALS AND METHODS: The latex from Hancornia speciosa (0.06-1.3mg/kg, p.o.) and the reference drug acetylsalicylic acid (ASA, 200mg/kg, p.o.) were evaluated in analgesia (formalin-induced licking, acetic acid-induced contortions, and hot plate) and inflammation models (formalin-induced licking, paw oedema, and subcutaneous air pouch, with measurement of cell migration, exudate volume, protein extravasations, nitric oxide, prostaglandin E2, TNF-α, and IL-6, and expression of the enzymes inducible nitric oxide synthase and cyclooxygenase 2). RESULTS: The latex from Hancornia speciosa significantly inhibited the number of writhings and the time that the animal spent licking the formalin-injected paw (second phase). Doses of 0.1-1.3mg/kg latex reduced carrageenan-induced rat paw oedema. However, only the highest doses (0.6 and/or 1.3mg/kg) reduced the oedema induced by bradykinin, histamine, and serotonin. The latex also inhibited inflammation induced by subcutaneous carrageenan injection, cell migration, exudate volume, protein extravasations, increased levels of inflammatory mediators (nitric oxide, prostaglandin E2, TNF-α, and IL-6) produced in the pouch, and increased expression of the enzymes nitric oxide synthase and cyclooxygenase 2. CONCLUSIONS: Our results indicate that the latex obtained from Hancornia speciosa demonstrates significant anti-inflammatory activity through the inhibition of nitric oxide, PGE2, and cytokine production, thus confirming the popular use of this plant as an anti-inflammatory agent.
AIM OF THE STUDY: Hancornia speciosa Gomes (Apocynaceae) is a tree that is widely distributed throughout Brazil. Its latex is collected and used extensively to treat acne, warts, diseases related to bursitis, and inflammation. In this work, we describe the anti-inflammatory effects of the latex. MATERIALS AND METHODS: The latex from Hancornia speciosa (0.06-1.3mg/kg, p.o.) and the reference drug acetylsalicylic acid (ASA, 200mg/kg, p.o.) were evaluated in analgesia (formalin-induced licking, acetic acid-induced contortions, and hot plate) and inflammation models (formalin-induced licking, paw oedema, and subcutaneous air pouch, with measurement of cell migration, exudate volume, protein extravasations, nitric oxide, prostaglandin E2, TNF-α, and IL-6, and expression of the enzymes inducible nitric oxide synthase and cyclooxygenase 2). RESULTS: The latex from Hancornia speciosa significantly inhibited the number of writhings and the time that the animal spent licking the formalin-injected paw (second phase). Doses of 0.1-1.3mg/kg latex reduced carrageenan-induced ratpaw oedema. However, only the highest doses (0.6 and/or 1.3mg/kg) reduced the oedema induced by bradykinin, histamine, and serotonin. The latex also inhibited inflammation induced by subcutaneous carrageenan injection, cell migration, exudate volume, protein extravasations, increased levels of inflammatory mediators (nitric oxide, prostaglandin E2, TNF-α, and IL-6) produced in the pouch, and increased expression of the enzymes nitric oxide synthase and cyclooxygenase 2. CONCLUSIONS: Our results indicate that the latex obtained from Hancornia speciosa demonstrates significant anti-inflammatory activity through the inhibition of nitric oxide, PGE2, and cytokine production, thus confirming the popular use of this plant as an anti-inflammatory agent.
Authors: Francielly Andressa Felipetti; Victor Seabra Lima Prado Costa; Juliana Dos Santos Neves; Ingrid Grazielle Sousa; Sônia Maria De Stefano Piedade; Pedro Duarte Novaes Journal: Rev Bras Ortop (Sao Paulo) Date: 2022-01-20
Authors: Luciane Madureira Almeida; Juliana Ferreira Floriano; Thuanne Pires Ribeiro; Lais Nogueira Magno; Lígia Souza Lima Silveira da Mota; Nei Peixoto; Fátima Mrué; Paulo Melo-Reis; Ruy de Souza Lino Junior; Carlos Frederico de Oliveira Graeff; Pablo José Gonçalves Journal: J Mater Sci Mater Med Date: 2014-06-29 Impact factor: 3.896
Authors: Uilson P Santos; Jaqueline F Campos; Heron Fernandes V Torquato; Edgar Julian Paredes-Gamero; Carlos Alexandre Carollo; Leticia M Estevinho; Kely de Picoli Souza; Edson Lucas Dos Santos Journal: PLoS One Date: 2016-12-01 Impact factor: 3.240
Authors: Uilson Pereira Dos Santos; Georgina S Tolentino; Jorge Sá Morais; Kely de Picoli Souza; Leticia M Estevinho; Edson Lucas Dos Santos Journal: Oxid Med Cell Longev Date: 2018-06-28 Impact factor: 6.543
Authors: Jun Zhao; Aosimanjiang Maitituersun; Chenyang Li; Qian Li; Fang Xu; Tao Liu Journal: Evid Based Complement Alternat Med Date: 2018-07-05 Impact factor: 2.629
Authors: José Tarcísio de Giffoni de Carvalho; Débora da Silva Baldivia; Daniel Ferreira Leite; Laura Costa Alves de Araújo; Priscilla Pereira de Toledo Espindola; Katia Avila Antunes; Paola Santos Rocha; Kely de Picoli Souza; Edson Lucas Dos Santos Journal: Oxid Med Cell Longev Date: 2019-08-25 Impact factor: 6.543
Authors: Manoela Torres-Rêgo; Allanny Alves Furtado; Mariana Angélica Oliveira Bitencourt; Maira Conceição Jerônimo de Souza Lima; Rafael Caetano Lisbôa Castro de Andrade; Eduardo Pereira de Azevedo; Thaciane da Cunha Soares; José Carlos Tomaz; Norberto Peporine Lopes; Arnóbio Antônio da Silva-Júnior; Silvana Maria Zucolotto; Matheus de Freitas Fernandes-Pedrosa Journal: BMC Complement Altern Med Date: 2016-08-05 Impact factor: 3.659
Authors: Mardonny Bruno de Oliveira Chagas; Irailton Prazeres Dos Santos; Luis Claudio Nascimento da Silva; Maria Tereza Dos Santos Correia; Janete Magali de Araújo; Marilene da Silva Cavalcanti; Vera Lucia de Menezes Lima Journal: Open Microbiol J Date: 2017-09-21